Search Results - "Alahmari, Ali D."

An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease by Kassim, Adetola A., de la Fuente, Josu, Nur, Erfan, Wilkerson, Karina L., Alahmari, Ali D., Seber, Adriana, Bonfim, Carmem, Simões, Belinda Pinto, Alzahrani, Mohsen, Eckrich, Michael J., Horn, Biljana, Hanna, Rabi, Dhedin, Nathalie, Rangarajan, Hemalatha G., Gouveia, Roseane Vasconcelos, Almohareb, Fahad, Aljurf, Mahmoud, Essa, Mohammed, Alahmari, Bader, Gatwood, Katie, Connelly, James A., Dovern, Elisabeth, Rodeghier, Mark, DeBaun, Michael R.

“…•For most adults with sickle cell disease, haploidentical BMT with thiotepa + PTCy is now a widely available curative option with excellent outcomes.•For…”
Get full text

Chimeric Antigen Receptor Structure and Manufacturing of Clinical Grade CAR Engineered Cells using Different Bioreactors by Syed, Farhatullah, El Fakih, Riad, Alahmari, Ali D, Osman Ali, Ahmed S, Aljurf, Mahmoud

Get full text

The Quality of Life of Sickle Cell Disease Patients in Saudi Arabia 2023 by Nasiri, Abdulrahman, Alahmari, Ali D

“…The quality of life of sickle cell disease patients in Saudi Arabia 2023. Sickle cell disease (SCD) is a genetic blood disorder that affects millions of people…”
Get full text

Excellent Outcomes of HLA Matched Related Donor Transplant for Adults with Severe Sickle Cell Disease Using a Non-Myeloablative Conditioning with Thiotepa and Post-Transplant Cyclophosphamide: Multi-Center International Experience by Alasbali, Reem, Alzahrani, Mohsen, Alhayli, Saud, Rasheed, Walid, Akhom, Phavina, Wilkerson, Karina, Essa, Mohammed, Elfakih, Riad, Alahmari, Bader, Samarkandi, Hadeel, Ahmed, Syed Osman, Saad, Ayman, Alzahrani, Hazza A., Almohareb, Fahad, Aljurf, Mahmoud, Kassim, Adetola A., Alahmari, Ali D

“…Introduction: The validated curative treatment for sickle cell disease (SCD) is allogeneic hematopoietic stem-cell transplantation (HSCT). Despite paucity of…”
Get full text

The Outcome of Tisagenlecleucel (Tisa-Cel) Vs Axicabtagene Ciloleucel (Axi-Cel) CD-19 CAR-T Cell Therapy in Relapsed/Refractory NHL, Real World Data, Single Institution Experience by Alasbali, Reem, Nasiri, Abdulrahman, Adam, Alfadil, Alhayli, Saud, Chaudhri, Naeem A., Alshaibani, Alfadel, Albabtain, Abdulwahab, Samarkandi, Hadeel, Saad, Ayman, Alamer, Abdullah, Elhassan, Tusneem Ahmed M, Alzahrani, Hazza A., Ahmed, Syed Osman, Rasheed, Walid, Elfakih, Riad, Aljurf, Mahmoud, Alahmari, ALI D

“…ABSTRACT Background: In the Kingdom of Saudi Arabia, non-Hodgkin lymphoma (NHL) reported as 6.1%. The estimated age adjusted incidence is 6/100,000. The more…”
Get full text

Superior Outcome of Bone Marrow Transplantation Using Fludarabine and Cyclophosphamide with ATG over Fludarabine and Cyclophosphamide without ATG Conditioning Regimen in Severe Aplastic Anemia by Alasbali, Reem, El Fakih, Riad O., Chaudhri, Naeem A., Alhayli, Saud, Alsharif, Fahad, Hanbali, Amr, Alfraih, Feras Abdulaziz, Shaheen, Marwan, Alfayez, Mansour, Alshaibani, Alfadel, Albabtain, Abdulwahab, Alotaibi, Ahmad S., Samarkandi, Hadeel, Kotb Abdrabou, Ahmed, Saad, Ayman, Alamer, Abdullah, Elhassan, Tusneem Ahmed M, Rasheed, Walid, Almohareb, Fahad, Alzahrani, Hazza A., Ahmed, Syed Osman, Aljurf, Mahmoud, Alahmari, ALI D

“…ABSTRACT Background: Matched sibling donor (MSD) allogenic hematopoietic stem cell transplantation (allo-HSCT) is the standard of care as the first line…”
Get full text

Allogeneic Stem Cell Transplantation in Adolescent and Adult Patients with Acute T Cell Lymphoblastic Leukemia / Lymphoma : Single Center Experience of 143 Patients by Mohammed Saleh, Mostafa Faisal, Kotb Abdrabou, Ahmed, Hummadi, Yahya, Elatassi, Nader, Hussain, Taimor, Alfadhil, Haroon, Bin salman, Ahmed, Nassani, Momen, Bajuaifer, Yazeed, Sharif, Mohamed Isam, Nassar, Marwa, Samarkandi, Sarah, Madien, Heba, Hejab, Amal, Alnughmush, Ahmed, Alyamany, Ruah, Alamer, Abdullah, Saad, Ayman, Alfayez, Mansour, Albabtain, Abdulwahab, Alotaibi, Ahmad S., Alshaibani, Alfadel, Alhayli, Saud, Shaheen, Marwan, Alahmari, Ali D, Alfraih, Feras Abdulaziz, Elfakih, Riad, Ahmed, Syed Osman, Rasheed, Walid, Chaudhri, Naeem A., Alsharif, Fahad, Alzahrani, Hazza A, Almohareb, Fahad, Aljurf, Mahmoud, Hanbali, Amr

“…Background: T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/-LL) is an aggressive hematological neoplasm originates from T-cell progenitors. T-ALL and T-LL…”
Get full text

Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing by Alfaham, Manar, Alotaibi, Ahmad S., Rasheed, Walid, Alsuwaidan, Abdullah, Mufti, Ghulam, Shaheen, Marwan, Alfayez, Mansour, Alfares, Ahmed, Alzayed, Balqees, Bakshi, Nasir, Khogeer, Haitham A., Alhossiny, Midrar, Filimban, Najlaa, Chaudhri, Naeem A., Almohareb, Fahad, Hejab, Amal, Alyamany, Ruah, Alnughmush, Ahmed, Alsharif, Fahad, Hanbali, Amr, Alfraih, Feras Abdulaziz, Alhayli, Saud, Alahmari, Ali D, Alshaibani, Alfadel, Albabtain, Abdulwahab, Saad, Ayman, Alamer, Abdullah, Abdrabou, Ahmed, Bin salman, Ahmed, Haroon, Alfadil, Hussain, Taimoor, Mohammed Saleh, Mostafa Faisal, Samarkandi, Sarah, Nassani, Momen, Bajuaifer, Yazeed, Sharif, Mohamed Isam, Madien, Heba, Alasbali, Reem, Nassar, Marwa, Bahkali, Fahad, Almarrzoq, Deemah, Ramadan, Sahar, Youniss, Riad, Meyer, Brian, Elfakih, Riad, Alzahrani, Hazza A, Aljurf, Mahmoud, Ahmed, Syed Osman

“…Introduction Acute Myeloid Leukaemia (AML) is characterised by cytogenetic (CGN) abnormalities and or mutations in one or more of a number of genes that allow…”
Get full text